Ezeagu Chiamaka Norah, Omoleke Semeeh Akinwale, Kanmodi Kehinde Kazeem
School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
Cephas Health Research Initiative Inc, Ibadan, Nigeria.
BMC Glob Public Health. 2024 May 24;2(1):35. doi: 10.1186/s44263-024-00068-z.
The departure of pharmaceutical companies from Nigeria - a major source of antimicrobial drug supply in West Africa - increases the risk of an elevated burden of antimicrobial resistance (AMR) in Nigeria and the West Africa subregion. Urgent actions must be taken by relevant actors to address the increased risk of AMR.
制药公司纷纷离开尼日利亚(西非抗菌药物的主要供应源),这增加了尼日利亚和西非次区域抗菌药物耐药性(AMR)负担上升的风险。相关各方必须立即采取行动,应对AMR风险上升的问题。